Log in to save to my catalogue

Somatostatin receptor scintigraphy might be useful for detecting skeleton abnormalities in patients...

Somatostatin receptor scintigraphy might be useful for detecting skeleton abnormalities in patients...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2791472

Somatostatin receptor scintigraphy might be useful for detecting skeleton abnormalities in patients with multiple myeloma and plasmacytoma

About this item

Full title

Somatostatin receptor scintigraphy might be useful for detecting skeleton abnormalities in patients with multiple myeloma and plasmacytoma

Publisher

Berlin/Heidelberg: Springer-Verlag

Journal title

European journal of nuclear medicine and molecular imaging, 2010-01, Vol.37 (1), p.124-130

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer-Verlag

More information

Scope and Contents

Contents

Purpose
Somatostatin receptor expression has been demonstrated on a number of plasma cell lines. Therefore, we questioned whether somatostatin receptor scintigraphy (SRS) can be used to demonstrate in vivo multiple myeloma (MM) activity.
Methods
SRS was performed in newly diagnosed (
n
 = 9) or relapsing (
n
 = 18) MM patients...

Alternative Titles

Full title

Somatostatin receptor scintigraphy might be useful for detecting skeleton abnormalities in patients with multiple myeloma and plasmacytoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2791472

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2791472

Other Identifiers

ISSN

1619-7070

E-ISSN

1619-7089

DOI

10.1007/s00259-009-1199-5

How to access this item